netFormulary The Pennine Acute Hospitals NHS
NHS Trust Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
02.01 Positive inotropic drugs (0,0)
02.01.01 Cardiac glycosides (1,1)
Digoxin-specific antibody (1,0)
02.01.02 Phosphodiesterase type-3 inhibitors (1,1)
02.02 Diuretics (0,0)
02.02.01 Thiazides and related diuretics (4,5)
02.02.02 Loop diuretics (3,0)
02.02.03 Potassium-sparing diuretics and aldosterone antagonists (1,1)
Aldosterone antagonists (2,0)
02.02.04 Potassium-sparing diuretics with other diuretics (2,5)
02.02.05 Osmotic diuretics (1,0)
02.02.06 Mercurial diuretics (0,0)
02.02.07 Carbonic anhydrase inhibitors (0,0)
02.02.08 Diuretics with potassium (0,5)
02.03 Anti-arrhythmic drugs (0,0)
02.03.01 Management of arrhythmias (0,0)
02.03.02 Drugs for arrhythmias (0,1)
Supraventricular arrhythmias (2,0)
Supraventricular and ventricular arrhythmias (3,2)
02.04 Beta-adrenoceptor blocking drugs (9,16)
02.05 Drugs affecting the renin-angiotensin system and some other antihypertensive drugs (0,0)
02.05.01 Vasodilator antihypertensive drugs (4,9)
02.05.02 Centrally acting antihypertensive drugs (3,0)
02.05.03 Adrenergic neurone blocking drugs (1,0)
02.05.04 Alpha-adrenoceptor blocking drugs (1,5)
Phaeochromocytoma (2,0)
02.05.05 Drugs affecting the renin-angiotensin system (0,1)
02.05.05.01 Angiotensin-converting enzyme inhibitors (ACE inhibitors) (5,15)
02.05.05.02 Angiotensin-II receptor antagonists (5,5)
02.05.05.03 Renin inhibitors (0,2)
02.06 Nitrates, calcium-channel blockers, and potassium-channel activators (0,0)
02.06.01 Nitrates (3,1)
02.06.02 Calcium-channel blockers (6,6)
02.06.03 Other antianginal drugs (3,0)
02.06.04 Peripheral vasodilators and related drugs (2,3)
Other preparations used in peripheral vascular disease (0,1)
02.07 Sympathomimetics (1,0)
02.07.01 Inotropic sympathomimetics (4,0)
02.07.02 Vasoconstrictor sympathomimetics (4,0)
02.07.03 Cardiopulmonary resuscitation (1,0)
02.08 Anticoagulants and protamine (0,0)
02.08.01 Parenteral anticoagulants (0,1)
Heparin (1,0)
Low molecular weight heparins (1,3)
Heparinoids (1,0)
Hirudins (0,2)
Heparin flushes (1,0)
Epoprostenol (1,0)
Fondaparinux (1,0)
02.08.02 Oral anticoagulants (0,0)
Stroke Prevention in Atrial Fibrillation (7,0)
Treatment of DVT/PE (7,0)
VTE prophylaxis in hip/knee surgery (2,0)
02.08.03 Protamine sulphate (1,0)
02.09 Antiplatelet drugs (9,0)
02.10 Stable angina, acute coronary syndromes, and fibrinolysis (0,0)
02.10.01 Management of stable angina and acute coronary syndromes (0,0)
02.10.02 Fibrinolytic drugs (4,1)
02.11 Antifibrinolytic drugs and haemostatics (1,2)
02.12 Lipid-regulating drugs (0,0)
Statins (4,3)
Bile acid sequestrants (1,2)
Ezetimibe (1,0)
Fibrates (1,3)
Nicotinic acid group (0,2)
Omega-3 fatty acid compounds (1,1)
Other lipid modifying agents (2,0)
02.13 Local sclerosants (2,0)
netFormulary